Powerful Medical
23. December 2023
5 min to read

Validation of an Automated Artificial Intelligence System for 12‑lead ECG Interpretation

Overview:

Trained on over 1 million ECGs, the PMcardio Core AI ECG Model was evaluated across six diagnostic categories, outperforming primary care physicians by up to 73% and matching cardiologists in overall accuracy. Additionally, it demonstrated clear superiority over traditional ECG machine-generated diagnoses, which are limited by rule-based algorithms, restricted pattern recognition, and an inability to incorporate clinical context.

Published In: Journal of Electrocardiology
Presented Date: December 23, 2023

Highlights:

  • AI-powered system detects 20 essential diagnostic patterns and standard ECG measurements from 12-lead ECGs.
  • AI outperforms state-of-the-art CIE for 13 of 20 evaluated diagnostic patterns and is non-inferior for the remaining.
  • AI system has the potential to reduce burden on cardiologists and improve timely and efficient referral.

Background

The electrocardiogram (ECG) is one of the most accessible and comprehensive diagnostic tools used to assess cardiac patients at the first point of contact. Despite advances in computerized interpretation of the electrocardiogram (CIE), its accuracy remains inferior to physicians. This study evaluated the diagnostic performance of an artificial intelligence (AI)-powered ECG system and compared its performance to current state-of-the-art CIE.

Methods

An AI-powered system consisting of 6 deep neural networks (DNN) was trained on standard 12‑lead ECGs to detect 20 essential diagnostic patterns (grouped into 6 categories: rhythm, acute coronary syndrome (ACS), conduction abnormalities, ectopy, chamber enlargement and axis). An independent test set of ECGs with diagnostic consensus of two expert cardiologists was used as a reference standard. AI system performance was compared to current state-of-the-art CIE. The key metrics used to compare performances were sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1 score.

Results

A total of 932,711 standard 12‑lead ECGs from 173,949 patients were used for AI system development. The independent test set pooled 11,932 annotated ECG labels. In all 6 diagnostic categories, the DNNs achieved high F1 scores: Rhythm 0.957, ACS 0.925, Conduction abnormalities 0.893, Ectopy 0.966, Chamber enlargement 0.972, and Axis 0.897. The diagnostic performance of DNNs surpassed state-of-the-art CIE for the 13 out of 20 essential diagnostic patterns and was non-inferior for the remaining individual diagnoses.

Conclusion

Our results demonstrate the AI-powered ECG model’s ability to accurately identify electrocardiographic abnormalities from the 12‑lead ECG, highlighting its potential as a clinical tool for healthcare professionals.


Authors: Robert Herman, MD, Anthony Demolder, MD, PhD, Boris Vavrik, MSc, Michal Martonak, MSc, Viera Kresnakova, MSc, PhD, Andrej Iring, MSc, Timotej Palus, Ing, Jakub Bahyl, MSc, Olivier Nelis, MSc, Monika Beles, RN, Davide Fabbricatore, MD, Leor Perl, MD, Jozef Bartunek, MD, PhD, Robert Hatala, MD, PhD

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

ECG Patterns of Occlusion Myocardial Infarction: a Narrative Review

This comprehensive review highlights the limitations of the traditional STEMI/NSTEMI classification for heart attacks and advocates for a more precise approach to diagnosis and patient triage. Instead of relying solely on standard ECG criteria, this method focuses on ECG patterns that more accurately reflect the severity of underlying coronary vessel disease. By identifying high-risk ECG changes beyond current STEMI guidelines, clinicians can detect heart attacks earlier, initiate treatment faster, and ultimately improve patient outcomes.

Artificial Intelligence–Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality: AI-ECG TIMI Study Design and Rationale

The AI-ECG TIMI study is a unique, multicenter registry currently enrolling patients to evaluate an AI-powered ECG model for detecting actively obstructed arteries in acute coronary syndrome (ACS). It is the first study to collect standard 12-lead ECGs precisely at the time of coronary angiography, providing novel insights into coronary occlusion and reperfusion. By identifying high-risk ECG patterns and assessing AI’s role in predicting intervention success, it paves the way for AI-driven precision cardiology in acute care.

Join 25,000 healthcare professionals who are already taking advantage of AI